Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

How to Play
Score 0/68 Timer 20:00
Dose: SC injection 2-3 times weekly
MOA: Antimetabolite and antifolate
IFN beta 1-a (Rebif) class
Use: For pts who do not respond to corticosteroids during acute attacks
First line drugs for disease modification
Use: Depression. Also helps with pain
Use: treatment of spasticity
Modafinil class
IFN beta 1-a (Avonex) class
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
Second line agent MOA: monoclonal Ab
Axathioprine class
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
Glatiramer acetate class
Use: Fatigue, cognitive impairment (long acting agent)
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Use: Fatigue
Off line agent used in the treatment of acute attacks
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
Dose: IM weekly
Duloxetine class
MOA: alkylating agent
Second line agent given IV monthy
Dose: IV infusion every 3 months
Rituximab class
Dose: Oral daily (first PO MS drug)
First line RRMS agent injected SC daily
Venlafaxine class
MOA: Immune modulator, exact mechanism not known.
Dose: 1 gram/day IV for 3-5 days
MOA: Anti-organ rejection drug
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Cyclophosphamide class
Excreted by kidney: contraindicated in moderate to severe renal failure
Carbamazepine class
MOA: Purine analog
Second line agent for RRMS that produces reduction in progression of disabilty
Second line agent: RRMS. Reduced relapses & progression of disability
Dose: Oral. In extreme cases intrathecal
Dose: 1250 mg/day PO for 3-5 days
Tricyclic class
Prednisone class
Alemtizumab class
Use: pain and paroxysmal disorders
Natalizumab class
Plasmapheresis class
IFN beta 1-b (Betaseron) class
Gabapentin class
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
Daclizumab class
Methylprednisone class
Use: Depression. Also helps with fatigue
Methylphenidate class
Baclofen class
Fingolimod class
Mitoxantrone class
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Mycophenolate class
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Dose: SC injection every other day
Tizanidine class
MOA: Immunomodulator/antineoplastic
Dalfampridine class
Methotrexate class
Bupropion class

Friend Scores

  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...


Created Oct 18, 2011ReportNominate
Tags:agent, multiple